|Page (1) of 1 - 10/25/11||email article||print page|
What's Ahead: Today's Economic Outlook - Equity Research on Thoratec Corporation and C.R. Bard, Inc.(October 25, 2011)
MACAU -- (Marketwire) -- 10/25/11 -- Today, www.EquityMarketsInc.com announced its research report highlighting Thoratec Corporation (NASDAQ: THOR) and C.R. Bard, Inc. (NYSE: BCR). Full content and research is available at www.EquityMarketsInc.com/research.php?id=THOR+BCR.
Short-term outlooks within US and global economies continue to adjust downward, as US Treasury yields touched their lowest levels in over 65 years. International Monetary Fund downgraded estimates for US growth by 1.0% this year, down from 2.5%. 'Significant downside risks' to the US economy were confirmed by the Federal Reserve pressured by 'strains in global financial markets'.
As the US dollar trades above an eight-month high against the Euro, it highlights a deepening of the Eurozone sovereign debt crisis -- furthered by continued policy inaction from European governments. We expect continued volatility until economic data stabilizes and we see decisive policy action to deal with the Eurozone debt crisis.
Our members are preparing for a turn in tides. Currently, the Credit Suisse Risk Appetite Indicator is at a 30-year low. For the past three occurrences, this level has acted as a leading indicator of large stock market rallies 18 months following.
Equity Markets has reviewed Thoratec Corporation for its current position within the healthcare industry. Thoratec Corporation is a manufacture of mechanical circulatory support (MCS) with a product portfolio to treat a range of clinical needs for advanced heart failure patients. The Company develops, manufactures and markets medical devices used for circulatory support. The full research report on Thoratec Corporation (NASDAQ: THOR) is available here: www.EquityMarketsInc.com/research.php?id=THOR.
Equity Markets has reviewed C.R. Bard, Inc. for its development within the healthcare industry. C. R. Bard, Inc. (Bard) is engaged in the design, manufacture, packaging, distribution and sale of medical, surgical, diagnostic and patient care devices. As of December 31, 2010, the Company sold a range of products to hospitals, individual healthcare professionals, extended care facilities and alternate site facilities on a global basis. The full research report on C.R. Bard, Inc. (NYSE: BCR) is available here: www.EquityMarketsInc.com/research.php?id=BCR.
About Equity Markets
Our mission at Equity Markets is to be the best source of content and research, while educating, enlightening and informing investors. Equity Markets combines street smart analysts and professional market researchers to provide investors with detailed company profiles and market coverage.
Copyright @ Marketwire
Related Keywords: Equity Markets Inc, Marketwire, Inc., , Financial, Medical Technology,